5 completed, 3 unknown, 2 withdrawn. 10 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 5, Unknown 3, Withdrawn 2 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Abciximab: new trials by email Literature Review of Abciximab trials Research Report on Abciximab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis Abciximab, Placebo, Intravenous hydration - Sickle Cell Disease, Hb-SS Disease With Vasoocclusive Pain | Phase 2 | Withdrawn | St. Louis University | 2013-11-01 | 2015-03-26 | |
| Exploratory P2 Trial to Evaluate Efficacy and Safety of Clotinab® (Abciximab) in Acute MI Patients Abciximab, Placebo - Acute Myocardial Infarction | Phase 2 | Unknown | ISU Abxis Co., Ltd. | 146 | 2013-05-01 | 2017-03-22 |
| Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients ALX-0081, ReoPro® - Unstable Angina, Non ST Segment Elevation Myocardial Infarction (NSTEMI) | Phase 2 | Completed | Ablynx, a Sanofi company | 364 | 2009-09-01 | 2023-04-04 |
| Aspirin Resistance and Percutaneous Coronary Intervention (PCI) Intravenous Glycoprotein inhibitor + ASA, Clopidogrel, Antiplatelet Therapy (ASA, Clopidogrel) - Stable Angina | Phase 2 | Completed | Icahn School of Medicine at Mount Sinai | 36 | 2007-04-01 | 2018-02-14 |
| Primary Angioplasty for Acute Myocardial Infarction in Patients With Symptom Duration Above 12 Hours Primary angioplasty with stent and abciximab - Acute Myocardial Infarction | Phase 2 | Completed | Aarhus University Hospital Skejby | 60 | 2005-05-01 | 2008-05-22 |
| Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee abciximab, stent and drug eluting stent - Patients Above 18 Years | Phase 2 | Unknown | University Hospital Tuebingen | 2003-09-01 | 2006-09-12 | |
| ReoPro and Retavase to Treat Acute Stroke Reopro, Retrovase - Cerebrovascular Accident | Phase 2 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 72 | 2002-09-24 | 2017-07-02 |
| ReoPro and Retavase to Restore Brain Blood Flow After Stroke Abciximab (ReoPro) and Reteplase (Retavase) - Cerebrovascular Accident | Phase 2 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 42 | 2002-03-01 | 2011-09-21 |
| Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease Balloon Angioplasty, ReoPro - Arterial Occlusive Diseases | Phase 2 / Phase 3 | Unknown | University Hospital Tuebingen | 420 | 2002-01-01 | 2006-09-12 |
| Stroke Prevention With Abciximab in Carotid Endarterectomy Abciximab - Carotid Stenosis | Phase 1 / Phase 2 | Withdrawn | University of Rochester | 2015-12-18 |
Angina, Stable (2) · Stroke (2) · Anemia, Sickle Cell (1) · Angina, Unstable (1) · Arterial Occlusive Diseases (1) · Carotid Stenosis (1) · Death (1) · Hemorrhage (1) · Non-ST Elevated Myocardial Infarction (1) · Peripheral Vascular Diseases (1) · Vaso-Occlusive Crises (1)
National Institute of Neurological Disorders and Stroke (NINDS) (2) · University Hospital Tuebingen (2) · Aarhus University Hospital Skejby (1) · Ablynx, a Sanofi company (1) · ISU Abxis Co., Ltd. (1) · Icahn School of Medicine at Mount Sinai (1) · St. Louis University (1) · University of Rochester (1)
United States (5) · Germany (4) · Austria (1) · Belgium (1) · Czechia (1) · Denmark (1) · Israel (1) · Poland (1) · South Korea (1) · Switzerland (1)
Gunnar Tepe, MD (2) · Annapoorna S Kini, MD MRCP (1) · Iris Baumgartner, MD (1) · Josefin-Beate Holz, MD (1) · Myungho Jeong (1) · Steen D. Kristensen, MD (1) · William S Burgin, MD (1) · William S Ferguson, MD (1)